Singh Enakshi 4
4 · Zymergen Inc. · Filed Sep 7, 2022
Insider Transaction Report
Form 4
Singh Enakshi
Chief Financial Officer
Transactions
- Sale
Common Stock
2022-09-02$2.21/sh−3,928$8,681→ 466,027 total
Footnotes (2)
- [F1]The shares were sold to cover the tax obligation that occurred upon the vesting of RSUs.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices no more than $2.31 and no less than $2.16, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.